Apixio is a pioneer in applying big data technology to extract and analyze clinical unstructured and coded data using natural language processing and machine learning to derive outcomes and cost-related insights. Based in Silicon Valley, Apixio offers solutions that enable health plans and large provider groups to more accurately and efficiently determine member risk scores and receive appropriate value-based reimbursement.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/27/14 | $13,500,000 | Series C | ||
| 05/24/16 | $19,300,000 | Series D |
First Analysis SSM Partners | undisclosed |
